Enrique Puertas Calvo
Dr. ENRIQUE PUERTASDr. ENRIQUE PUERTAS

Enrique Puertas Calvo

HEAD OF SERVICE
Radiation Oncologyen/specialities/radiation-oncology

CV Médicos biobuilder con centros Enrique Puertas Calvo

Centros en los que trabaja el profesional

See more specialists on Barcelonabarcelona

en/medical-staff/radiation-oncologist

Dr. Enrique Puertas Calvo is a leading specialist in Radiation Oncology, having graduated in Medicine from the Universitat de Barcelona in 2005. He currently serves as Head of Service at the Hospital Quirónsalud Barcelona , where he has led the Radiotherapy Department since 2021. His most significant publication, "Revisions in Cancer," addresses unresectable stage III large cell lung carcinoma and was published in January 2023. Furthermore, Dr. Puertas received third prize for his oral presentation entitled "How changes on the patient and tumor volumes impact on the dose distribution of locally advanced head and neck cancer," awarded by the Sociedad Española de Oncología Radioterápica (SEOR) in 2009. He is an active member of the Sociedad Española de Radiocirugía, contributing to the advancement of radiotherapy in Spain.

Key information

  • 3er premio por la comunicación oral How changes on the patient and tumor volumes impact on the dose distribution of locally advanced head and neck cancer
    2009
  • Latest Publication:
    68Ga-PSMA-11 PET/CT in patients with occult biochemical recurrence of prostate carcinoma and negative 18F-Choline PET/CT. Preliminary assessment of its clinical use.
  • Belongs to:
    Sociedad Española Radiocirugía

Professional Details

Hospital Quirónsalud Barcelona
HEAD OF SERVICE
August 2011 - Present
Escola Bonanova
Professor, 2nd Cycle, Higher Education for Technicians
January 2012 - January 2015
Hospital Universitari Vall D'Hebron
Residency as a MIR (Medical Resident)
January 2006 - January 2010
Study
Bachelor of Medicine
Universitat de Barcelona
2005
Specialized Healthcare Training
Radiation Oncology
Language
FIRST CERTIFICATE
Another qualification
Clinical workshop Minimal invasive treatment of early-stage breast cancer using brachy monotherapy
Another qualification
VIII Course on Clinical Indications in Radiation Oncology
Another qualification
SAP Healthcare Training Course
Another qualification
External rotation through Brachytherapy Unit
Another qualification
Physics course applied to clinical radiotherapy
Another qualification
Training Course for Supervisors of Radioactive Installations in the field of radiotherapy
Another qualification
X Theoretical-practical course on Clinical Radiobiology
Another qualification
Course on cancer pain
Another qualification
XVII Course on Tumors of the Musculoskeletal System: Sarcomas and Radiotherapy
Another qualification
Head and Neck Cancer Course: Planning
Breast Cancer: From A to Z – Information Day for Patients
BBCC (Barcelona Breast Cancer Center), Barcelona
January 2015 - Present
6th Intensive Conference on Radiochemotherapy in Lung Cancer: Table 6: Stage IV of NSCLC
Hospital Clínic i Provincial de Barcelona
January 2014 - Present
2nd IOB Conference-Discussion: Prevention and advances in lung cancer
H. Quirón
January 2012 - Present
2nd Cycle Higher Education for Radiotherapy Technicians
Escola Bonanova, Barcelona
January 2012 - January 2015
First Multidisciplinary Oncology Conference: Lung Cancer: Controversies in the treatment of stage IIIB NSCLC
H. Quirón Madrid
January 2012 - Present
A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Phase III Study of Post-Operative Adjuvant Lapatinib or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib or Placebo Monotherapy in High-Risk Subjects with Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)
GlaxoSmithKline
An Exploratory, Randomised, Parallel Group Study, Comparing the Protective Effect of Soluble Beta-1,3/1,6-Glucan or Placebo in Oral Mucositis in Head and Neck Cancer Patients Receiving Radiation Therapy or Chemoradiotherapy
Biotec Pharmacon ASA
Prospective clinical trial on partial breast irradiation in the conservative treatment of breast cancer
H. QuirónSalud Barcelona
Johnson A2Ar Clinical Trial
GEM-1802 Multicentre phase II clinical trial to evaluate the activity of encorafenib and binimetinib before local treatment in patients with BRAF mutated melanoma with metastasis to the brain
Spanish Multidisciplinary Melanoma Group
Randomized, double-blind study on the prevention and reduction of esophageal mucositis in patients undergoing radiotherapy and/or chemoradiotherapy for lung cancer with the nutritional supplement Bialobe (Aloe Vera)
Atlantia
BEIGENE Clinical Trial
Randomized phase II trial of panitumumab and radiotherapy (PRT) compared with chemoradiotherapy (QRT) in patients with locally advanced unresected squamous cell carcinoma of the head and neck
AMGEN
68Ga-PSMA-11 PET/CT in patients with occult biochemical recurrence of prostate carcinoma and negative 18F-Choline PET/CT. Preliminary assessment of its clinical use.
Journal Article
68Ga-PSMA-11 PET/CT in patients with occult biochemical recurrence of prostate carcinoma and negative 18F-Choline PET/CT. Preliminary assessment of its clinical use.
Journal Article
A dosimetric evaluation of the Eclipse AAA algorithm and Millennium 120 MLC for cranial intensity-modulated radiosurgery
Journal Article
Bladder cancer
Book chapter
Characterization of brachytherapy types
Book chapter
Dose variations in tumor volumes and organs at risk during IMRT for head-and-neck cancer
Journal Article
The role of radiotherapy in curing breast cancer
Article
Fatal gastrointestinal toxicity with ipilimumab after BRAF/MEK inhibitor combination in a melanoma patient achieving pathological complete response
Journal Article
Feasibility of an online adaptive replanning method for cranial frameless intensity-modulated radiosurgery
Journal Article
Lung cancer survival rates double thanks to technology
Article
Preliminary evaluation of cerebral 18F-DOPA PET/CT in the differential diagnosis of brain lesions in inconclusive MR.
Journal Article
Cancer Reviews
Book chapter
Timoma
Book chapter
Sociedad Española Radiocirugía
ESTRO
SEOR
SBRT Spanish Group
Fundació Academia de Ciencies Mèdiques i de la Salut de Catalunya i Balears
Fundació Acadèmia de Ciències Mèdiques i de la Salut de Catalunya i Balears
3er premio por la comunicación oral How changes on the patient and tumor volumes impact on the dose distribution of locally advanced head and neck cancer
SEOR
Catalan
Spoken and written perfectly
Castilian
Spoken and written perfectly
Make an appointment with this professional

Consulta el contenido multimedia de este profesional.

Hospitals

Book an appointment now at one of our hospitals.

Articles on

Browse the latest articles on Tu canal de salud.

No tienes seguro de saludNo tienes seguro de salud

¿No tienes seguro de salud?

Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.